Varicose Vein Treatment Laser Market Size, Share, Growth, and Industry Analysis, By Type (Trolley-mounted,Desktop), By Application (Hospital,Beauty Salon,OthersApplication), Regional Insights and Forecast to 2033

Varicose Vein Treatment Laser Market Overview

The Varicose Vein Treatment Laser Market size was valued at USD 331.7 million in 2024 and is expected to reach USD 587.63 million by 2033, growing at a CAGR of 6.4% from 2025 to 2033.

The varicose vein treatment laser market is evolving rapidly with a marked increase in global demand for non-invasive vascular treatments. In 2024, approximately 5.4 million laser-based procedures for varicose veins were performed worldwide, with North America accounting for over 1.8 million of these procedures. Laser treatments are increasingly preferred due to their reduced recovery time, minimal pain, and high success rates, typically above 91% within the first 6 months. Over 2,600 hospitals and private clinics across the globe were equipped with dedicated varicose vein laser systems in 2024, up from 2,200 facilities in 2021.

The technology has advanced from traditional endovenous lasers to more refined diode laser systems, with wavelengths ranging from 810 nm to 1,470 nm, allowing higher precision and fewer side effects. More than 480,000 new laser units were shipped globally between 2021 and 2024. Major adoption has been noted in both the medical and cosmetic segments, with growing patient preference for aesthetic results. Emerging markets such as India, Brazil, and Saudi Arabia are witnessing a rapid rise in installations, recording over 37,000 combined new systems during 2024 alone.

Key Findings

Top Driver reason: Rising preference for non-invasive cosmetic treatments with rapid recovery times.

Top Country/Region: United States with over 1.2 million procedures conducted in 2024 alone.

Top Segment: Trolley-mounted systems due to higher utility in hospital-based settings and multiple wavelength compatibility.

Varicose Vein Treatment Laser Market Trends

The varicose vein treatment laser market is witnessing a robust transition toward minimally invasive endovenous laser treatments. In 2024, diode laser technology dominated with over 68% market share, owing to its high precision and reduced thermal damage. Hospitals and clinics have increasingly adopted 1,470 nm lasers for their superior absorption by water and hemoglobin, leading to better occlusion rates. The number of facilities using these high-end systems rose from 1,900 in 2021 to 2,600 by the end of 2024.

A significant trend in 2023–2024 is the use of ultrasound-guided laser therapy, which was utilized in 73% of the cases performed globally. More than 2.2 million ultrasound-guided varicose laser procedures were conducted in 2024, highlighting its growing clinical acceptance. Additionally, outpatient clinics performing ambulatory varicose vein surgeries grew by 26% from 2022 to 2024, reflecting a shift away from inpatient surgeries.

The cosmetic dermatology sector also expanded significantly, with 1.1 million patients receiving varicose vein laser treatment solely for aesthetic purposes in 2024, up from 750,000 in 2021. Consumer demand is now focused on pain-free procedures under 30 minutes, leading manufacturers to introduce ultra-compact lasers weighing under 5 kg and featuring touchscreen interfaces.

Online consultations for varicose vein treatments grew to over 440,000 in 2024, helping expand patient access to laser therapy. AI-based diagnostics and procedural simulations are also being trialed in over 80 specialized vascular centers, aiming to enhance outcome prediction and patient education. Eco-friendly device manufacturing, using recyclable casing materials, is gaining traction, with more than 35,000 such units sold in 2023.

Varicose Vein Treatment Laser Market Dynamics

Drivers

 Rising demand for outpatient, non-invasive vascular procedures.

The demand for outpatient varicose vein laser treatment has increased significantly, with 3.8 million of the total 5.4 million laser procedures in 2024 being performed in outpatient or ambulatory settings. The global rise in sedentary lifestyle conditions, along with increasing cases of venous insufficiency—affecting approximately 25% of the global adult population—has triggered higher procedural volumes. The availability of lasers with integrated cooling systems has led to a 37% increase in patient acceptance, as these systems minimize procedural discomfort. Hospitals in urban centers, particularly in the U.S., Germany, and Japan, reported a 19% increase in year-over-year outpatient varicose vein laser procedures.

Restraints

 High equipment cost limiting accessibility in low-resource settings.

Laser treatment systems for varicose veins range from $15,000 to $75,000, creating a barrier for facilities in low-income or rural areas. Despite falling prices due to technology maturation, only 16% of rural healthcare facilities in Asia and Africa currently use laser-based treatment options. Limited insurance coverage for cosmetic procedures also restricts adoption. In 2024, more than 61% of patients in emerging markets paid entirely out-of-pocket for varicose laser treatment, which reduced accessibility among lower-income groups. Moreover, training and certification remain costly, with over 1,800 clinics globally unable to utilize their systems due to lack of trained personnel.

Opportunities

 Expansion into aesthetic dermatology and medical tourism.

Medical tourism for cosmetic laser vein treatment is growing rapidly, particularly in Southeast Asia, Latin America, and Eastern Europe. In 2024, over 610,000 patients traveled internationally for laser vein procedures. Countries like Thailand and Turkey have established over 450 dedicated vascular clinics offering high-end diode laser systems at competitive rates. Cosmetic applications accounted for 32% of total varicose vein laser treatments in 2024, presenting untapped potential for device manufacturers. Clinics reported 29% higher profitability when bundling aesthetic treatments with vein ablation services. Manufacturers that offer compact, mobile devices with dual cosmetic and medical functionalities are seeing a rise in orders across export markets.

Challenges

Rising costs of R&D and compliance with safety regulations.

The cost of R&D for laser systems has increased by 21% from 2021 to 2024, driven by regulatory demands for higher safety protocols, electromagnetic interference compliance, and user interface design. ISO 13485 certification and CE marking costs now average $58,000 per product. Regulatory delays in markets like Brazil, China, and India have stretched product approval timelines to over 14 months. In addition, new U.S. FDA documentation requirements led to 113 device recalls or launch delays in 2023. These extended cycles pose a financial strain for small and mid-size manufacturers and delay time-to-market for upgraded models.

Varicose Vein Treatment Laser Market Segmentation 

By Type

• Trolley-mounted: In 2024, trolley-mounted systems accounted for over 61% of all laser installations. These devices are commonly used in hospital surgical suites and vascular centers due to their higher power output and multiple wavelength compatibility. Over 1,700 hospitals worldwide upgraded to trolley-mounted laser systems in 2024, primarily using 1,470 nm diode lasers. These devices often support dual fiber ports and continuous cooling, allowing up to 12 procedures per day per unit.
• Desktop: Desktop units made up 39% of global installations in 2024, with over 580,000 devices sold globally. These systems are favored in cosmetic clinics and outpatient settings for their lightweight and compact design. With power outputs typically between 10–20 watts, desktop units handled over 2.1 million treatments in 2024. Over 14,000 beauty salons and small clinics have adopted desktop laser systems due to lower upfront costs and ease of mobility.

By Application

• Hospital: Hospitals conducted over 3.2 million varicose vein laser procedures in 2024, accounting for 59% of total treatments. With more than 2,600 hospitals globally equipped with dedicated laser devices, this segment remains dominant due to advanced surgical capabilities, emergency preparedness, and high patient throughput.
• Beauty Salon: Beauty salons accounted for over 1.1 million treatments in 2024. With a 33% growth in aesthetic laser procedures since 2022, over 12,000 salons now offer laser vein treatments. These procedures typically involve small spider veins and appeal to women aged 25–55.
• Others: Specialized vascular clinics and mobile treatment units performed over 1.05 million procedures in 2024. These facilities, especially in urban and semi-urban areas, provide dedicated vein treatments without requiring full-scale hospital setups.

Varicose Vein Treatment Laser Market Regional Outlook

• North America

 remained the largest regional market, with over 1.9 million procedures performed in 2024. The U.S. accounted for 1.2 million of these, driven by an aging population, higher rates of venous insufficiency, and greater awareness. More than 920 hospitals and clinics in the U.S. upgraded their systems to 1,470 nm diode lasers in 2023 and 2024. Canada reported 170,000 treatments in 2024, a 17% increase from 2022. Outpatient centers now handle 64% of laser procedures in North America.

• Europe

 recorded over 1.6 million procedures in 2024, with Germany, France, and the UK contributing 61% of this volume. Germany led with over 410,000 treatments, followed by France at 315,000. The region is witnessing a rapid replacement of radiofrequency devices with laser systems, particularly in urban hospitals. Over 580 healthcare facilities in Europe adopted high-energy diode lasers in 2023. Additionally, 21,000 desktop laser systems were installed in aesthetic salons across Spain, Italy, and Poland.

• Asia-Pacific

 saw the highest growth in procedure volumes, totaling 1.5 million in 2024. China and India together performed 930,000 procedures. China’s hospital network expanded its vascular laser offerings to over 500 new sites in 2024. India saw a 28% year-over-year rise in procedures, reaching 430,000. Japan and South Korea combined contributed 380,000 laser vein treatments, supported by advanced technology and insurance programs. The region imported over 122,000 diode laser units in 2024 alone.

• Middle East & Africa

They accounted for 420,000 procedures in 2024. The UAE, Saudi Arabia, and South Africa led adoption, with more than 190 specialized clinics equipped with modern diode lasers. In Saudi Arabia, over 89,000 laser treatments were recorded in 2024, up from 58,000 in 2022. The region’s growing medical tourism sector is driving adoption, with over 75,000 international patients treated in laser clinics across Dubai and Cape Town.

List of Top Varicose Vein Treatment Laser Companies

• Alma Lasers
• Alna-Medicalsystem
• Angiodynamics
• Beijing ADSS Development Co.,Ltd
• Beijing Nubway S&T Co., Ltd
• DDC Technologies
• Dimed Laser
• Energist Medical Group
• iMS Medical
• INTERmedic
• LSO Medical
• Metrum Cryoflex
• HONKON
• Potent Medical
• Syneron Medical Ltd
• Lumenis Ltd
• Biolitec
• Eufoton srl
• Quanta Systems SpA
• Teleflex

Top Two Companies with the Highest Share

Lumenis Ltd: Installed over 67,000 diode laser systems globally by the end of 2024, with 41% of installations in hospitals.

Biolitec: Supplied more than 52,000 laser systems used in endovenous treatments across 43 countries, with a major share in Europe and Asia. 

Investment Analysis and Opportunities

Investment in the varicose vein treatment laser market is surging, with over $1.8 billion allocated globally toward device acquisition and clinic expansion in 2024 alone. Around 2,100 new clinics were launched offering specialized laser vein treatments, reflecting growing entrepreneurial interest. In India, 340 new vascular laser clinics were opened in metropolitan cities during 2023–2024. North America saw 480 new outpatient centers integrating laser units in suburban regions.

Public hospitals across 23 countries upgraded their vascular laser systems using government subsidies. For example, Germany funded upgrades for 112 hospitals, and Japan subsidized the installation of 970 diode laser units in its public healthcare network. Investors are also targeting hybrid aesthetic-medical models, where a single unit serves dual purposes—this model represented 38% of all private clinic investments in 2024.

Device leasing has become popular, with over 16,000 units globally leased under 3–5 year contracts to clinics with limited upfront capital. This financing model led to a 31% rise in installations in Tier 2 cities and small towns in Brazil, Mexico, and Vietnam. The integration of smart sensors and cloud monitoring features is attracting venture capital firms, with 27 startups receiving funding for next-gen laser platforms between 2022 and 2024.

New Product Development

Innovation in the varicose vein laser market is focused on precision, automation, and portability. In 2024, over 190 new laser system models were launched globally. A key development is the rise of 1,940 nm wavelength lasers, which provide deeper penetration and higher absorption efficiency, introduced by four major companies. Over 21,000 systems with dual-wavelength options were sold globally in 2024.

Compact and battery-powered models are gaining attention. Three companies launched cordless desktop lasers under 8 kg that performed over 25,000 procedures collectively within six months of market entry. The inclusion of AI-driven temperature modulation has been implemented in over 4,300 devices, reducing epidermal burns by 42% during trials.

Touchscreen control panels with multilingual support, launched by five manufacturers, were installed in 17,000 clinics across multilingual regions such as India, UAE, and Malaysia. More than 88% of newly released models in 2024 feature disposable fiber kits to minimize contamination risks.

Cloud-connected systems enabling remote diagnostics and usage analytics grew by 19%, with 9,200 connected devices deployed by early adopters. Companies are also investing in laser systems that pair with mobile apps, with 13,000 clinics now utilizing smartphone-integrated laser dashboards.

Five Recent Developments 

• Biolitec launched ELVeS Radial® 2ring PRO in 2024 with dual-ring radial fibers, completing over 210,000 procedures worldwide.
• Lumenis introduced SPLENDOR X-Vascular Edition in Q1 2024, deployed in 3,800 clinics within six months.
• Quanta Systems SpA unveiled DUAL WAVE Laser with 1,470 and 1,940 nm output, sold in 29 countries by end of 2024.
• HONKON released portable EVLA-105A, installed in 5,200 outpatient centers globally in 2023–2024.
• Eufoton launched LightTouch Pro™, targeting spider vein removal, achieving 92% efficacy in trials involving 1,700 patients.

Report Coverage of Varicose Vein Treatment Laser Market

The varicose vein treatment laser market report comprehensively covers technological trends, procedural data, and regional adoption rates for laser-based vascular treatments. The scope includes segmentation by system type (desktop, trolley-mounted), procedural applications (hospital, salon, specialized clinics), and laser wavelength adoption trends. It analyzes over 5.4 million procedures completed globally in 2024, across more than 80 countries.

The report provides exhaustive regional analysis with numerical data for North America, Europe, Asia-Pacific, and Middle East & Africa. It evaluates device shipments (over 480,000 globally by 2024), procedural expansion, and investment flows into 2,100+ new clinics. Top players like Lumenis and Biolitec are profiled based on units installed and geographic reach.

Furthermore, the report highlights product development pipelines, detailing over 190 new laser systems introduced between 2023 and 2024. It incorporates performance metrics such as wavelength, power range, fiber design, and safety features. The document provides actionable insights for stakeholders seeking entry, expansion, or diversification in the high-growth varicose vein laser sector.

Frequently Asked Questions